KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr |
What is the latest Contingent Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.76 Cr |
| Mar2024 | ₹0.76 Cr |
| Mar2023 | ₹0.76 Cr |
| Mar2022 | ₹0.76 Cr |
| Mar2021 | ₹0.76 Cr |
How is Contingent Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.76 Cr | 0.00 | |
| Mar2024 | ₹0.76 Cr | 0.00 | |
| Mar2023 | ₹0.76 Cr | 0.00 | |
| Mar2022 | ₹0.76 Cr | 0.00 | |
| Mar2021 | ₹0.76 Cr | - | |
Compare Contingent Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹536.6 Cr | 1.7% | 11.4% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 1.7% |
11.4% |
-11.1% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses